• 1
    Scoazec JY, Durand F, Degott C, Delautier D, Bernuau J, Belghiti J, Benhamou JP, et al. Expression of cytokine-dependent adhesion molecules in postreperfusion biopsy specimens of liver allografts. Gastroenterology 1994; 107: 10941102.
  • 2
    Strassberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829838.
  • 3
    Gonzalez XF, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, Lacy AM, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20: 565573.
  • 4
    Arthur MJP, Bently IS, Tanner AR, Kowalski Saunders P, Millward Sadler GH, Wright R. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology 1985; 89: 11141122.
  • 5
    Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Rad Biol Med 1988; 5: 409419.
  • 6
    Hasuoka H, Sakagami K, Orita K. A new slow delivery type of superoxide dismutase prevents warm ischemia damage in swine orthotopic liver transplantation. Transplant Proc 1991; 23: 693696.
  • 7
    Matthews WR, Guido DM, Fisher MA, Jaeschke H. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Rad Biol Med 1994; 16: 763770.
  • 8
    Jaeschke H, Smith CV, Mitchell JR. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest 1988; 81: 12401246.
  • 9
    Colletti LM, Remick DG, Burtch GD, Kunkel SL, Streiter RM, Campbell DA. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 19361943.
  • 10
    Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Stricter RM. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. J Clin Invest 1995; 95: 134141.
  • 11
    Suzuki S, Toledo-Pereyra LH. Interlukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 1994; 57: 253258.
  • 12
    Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 33553359.
  • 13
    Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res 1991; 15: 277284.
  • 14
    Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, Guth PH, et al. Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 1992; 262: 669676.
  • 15
    Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemia livers. Transplantation 1985; 40: 584590.
  • 16
    Fujita T, Furitsu H, Nishikawa M, Takakura Y, Sezaki H, Hashida M. Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion. Biomed Biophys Res Commun 1992; 189: 191196.
  • 17
    Kawamoto S, Inoue M, Tashiro S, Morino Y, Miyauchi Y. Inhibition of ischemia and reflow-induced liver injury by an SOD derivative that circulates bound to albumin. Arch Biochem Biophys 1990; 277: 160165.
  • 18
    Jerome SN, Smith CW, Korthuis RJ. CD18-dependent adherence reactions play an important role in the development of the noreflow phenomenon. Am J Physiol 1993; 264: 479483.
  • 19
    Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Wayne SC. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD 18) monoclonal antibody protects against ischemiareperfusion injury in rat liver. Hepatology 1993; 17: 915923.
  • 20
    Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and aschemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: 355362.
  • 21
    Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion-in-duced microvascular injury. Am J Physiol 1987; 253: 699703.
  • 22
    Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK. Neutrophils contribute to hepatic ischemia-reperfusion injury by a CD18-independent mechanism. J Leukoc Biol 1993; 53: 511517.
  • 23
    Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991; 14: 421451.
  • 24
    Dragunow M, Young D, Hughs P, MacGibbon G, Lawlor P, Singleton K, Sirimanne E, et al. Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? Brain Res Mol Brain Res 1993; 18: 347352.
  • 25
    Goto S, Matsumoto I, Kamada N, Bui A, Saito T, Findlay M, Pujic Z, et al. The induction of immediate early genes in postischemic and transplanted livers in rats. Its relation to organ survival. Transplantation 1994; 58: 840845.
  • 26
    Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, et al. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363: 166169.
  • 27
    Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM. Altered gene expression in neurons during programed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 1994; 127: 17171727.
  • 28
    Schiaffonati L, Rappocciolo E, Tacchini L, Cairo G, Bernelli-Zazzera A. Reprogramming of gene expression in postischemic rat liver: induction of proto-oncogenes and hsp 70 gene family. J Cell Physiol 1990; 143: 7987.
  • 29
    Colotta F, Polentarutti N, Sironi M, Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992; 267: 1827818283.
  • 30
    Mollinedo F, Gajate C, Modolell M. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Biochem J 1994; 302: 325329.
  • 31
    Goldstone SD, Lavin MF. Prolonged expression of c-jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukaemic cell line. Oncogene 1994; 9: 23052311.
  • 32
    Migliorati G, Nicoletti I, Nocentini G, Pagliacci MC, Riccardi C. Dexamethasone and interleukins modulate apoptosis of murine thymocytes and peripheral T-lymphocytes. Pharmacol Res 1994; 30: 4352.
  • 33
    Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 1994; 46: 605611.
  • 34
    Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death [Review]. Am J Pathol 1995; 146: 315.
  • 35
    Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N. Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology 1991; 15: 507514.
  • 36
    Adkinson D, Hollwarth ME, Benoit JN, Parks DA, McCord JM, Granger N. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand 1986; 548: 101107.
  • 37
    Karin M, Yang-Yen HF, Chambard JC, Deng T, Saatcioglu F. Various modes of gene regulation by nuclear receptors for steroid and thyroid hormones [Review]. Eur J Clin Pharmacol 1995; 45: S915, S43–44.